These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16840182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T, Nochy D, Montravers F, Der Sahakian G, Fior R, Galanaud P, Boué F.
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [Abstract] [Full Text] [Related]

  • 5. Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
    Ganjoo KN, An CS, Robertson MJ, Gordon LI, Sen JA, Weisenbach J, Li S, Weller EA, Orazi A, Horning SJ.
    Leuk Lymphoma; 2006 Jun; 47(6):998-1005. PubMed ID: 16840188
    [Abstract] [Full Text] [Related]

  • 6. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C.
    N Engl J Med; 2002 Jan 24; 346(4):235-42. PubMed ID: 11807147
    [Abstract] [Full Text] [Related]

  • 7. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
    Fowler NH.
    Clin Adv Hematol Oncol; 2014 Sep 24; 12(9):608-10. PubMed ID: 25654483
    [No Abstract] [Full Text] [Related]

  • 8. BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
    Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH.
    Blood; 2007 Jan 15; 109(2):843-4; discussion 844-5. PubMed ID: 17210865
    [No Abstract] [Full Text] [Related]

  • 9. [Spindle cell variants of diffuse large B cell lymphoma: report of 2 cases].
    Wang JC, Shi DR, Fu XL, Lu CL, Lu WP.
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan 15; 34(1):55-6. PubMed ID: 15796885
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
    Lin PC, Hsiao LT, Poh SB, Wang WS, Yen CC, Chao TC, Liu JH, Chiou TJ, Chen PM.
    Ann Hematol; 2007 Feb 15; 86(2):95-100. PubMed ID: 17031689
    [Abstract] [Full Text] [Related]

  • 12. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity.
    Jaradat JM, Potluri A, Bilodeau EA.
    Indian J Dent Res; 2013 Feb 15; 24(3):384-6. PubMed ID: 24025890
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
    Takács I, Eros N, Bene I, Bozsó F, Tordai L, Károlyi Z, Radványi G, Matolcsy A.
    Ann Hematol; 2004 Sep 15; 83(9):608-10. PubMed ID: 15205915
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M, Okamoto K, Chonabayashi K, Kaneko H, Watanabe M, Tsudo M.
    Br J Haematol; 2007 Feb 15; 136(3):351. PubMed ID: 17233843
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.